Effect of Physician-Pharmacist Collaborative Management Mode on Risk Factor Control in Patients After Percutaneous Coronary Intervention
Objective To investigate the effect of physician-pharmacist collaborative management mode on the risk factor control in patients after percutaneous coronary intervention(PCI).Methods A total of 180 patients who underwent PCI at the People's Hospital of Yingshang from January 2020 to November 2021 were selected and divided into the observation group(physician-pharmacist collaborative management mode)and the control group(physician management mode)by a random number table method,with 90 cases in each group.The patients were received follow-up visits once a month for six months.Results There was no significant difference in clinical indicators between the two groups at discharge(P＞0.05).At the follow-up visits of six months,the standard-reaching rates of low-density lipoprotein cholesterol(LDL-C,75.56％vs.48.89％,P＜0.001),non-high-density lipoprotein cholesterol(non-HDL-C,64.44％vs.45.56％,P=0.011)and heart rate(22.22％vs.6.67％,P=0.003),the use rates of β-receptor antagonist(75.56％vs.53.33％,P=0.002)and angiotensin converting enzyme inhibitor/angiotensin Ⅱ receptor blockers(ACEI/ARB,77.78％vs.53.33％,P=0.001)and Morisky Medication Adherence Scale score[(7.74±0.46)points vs.(7.11±0.77)points,P＜0.001]in the observation group were significantly higher than those in the control group.There was no significant difference in the incidence of adverse events between the two groups(2.22％vs.0,P＞0.05).Conclusion Physician-pharmacist collaborative management mode can improve the risk factor control and medication adherence in patients after PCI.
万方数据
维普
